A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer.
WestVac Biopharma Co., Ltd.
WestVac Biopharma Co., Ltd.
Hospital Universitari de Bellvitge
Cancer Research UK
Rutgers, The State University of New Jersey
Unity Health Toronto
Peking University
Universidade Federal de Pernambuco
Zhongnan Hospital
Alpha Tau Medical LTD.